Afferent baroreflex failure and tako-tsubo cardiomyopathy.

Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy. PLoS One (2014) 0.79

Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med (2005) 17.61

Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. J Am Coll Cardiol (2001) 12.56

Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med (2004) 11.40

Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest (2007) 8.08

Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med (2008) 4.91

Apical ballooning of the left ventricle: first series in white patients. Heart (2003) 4.12

The diagnosis and treatment of baroreflex failure. N Engl J Med (1993) 3.45

Tako-tsubo cardiomyopathy in a patient with bilateral lesions in the dorsal medulla. Clin Auton Res (2010) 1.84

Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J (2007) 1.81

Impact of earthquakes on Takotsubo cardiomyopathy. JAMA (2005) 1.81

Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy. Eur Heart J (2009) 1.78

Afferent baroreflex failure in familial dysautonomia. Neurology (2010) 1.25

Apical ballooning syndrome after administration of intravenous epinephrine during an anaphylactic reaction. Mayo Clin Proc (2009) 1.16

Images in cardiovascular medicine. Pheochromocytoma-related cardiomyopathy: inverted Takotsubo contractile pattern. Circulation (2006) 1.12

Baroreflex failure in a patient with central nervous system lesions involving the nucleus tractus solitarii. Hypertension (1994) 0.94

Recurrent takotsubo cardiomyopathy associated with pheochromocytoma. Endocr Pract (2009) 0.82

Cardiogenic shock with basal transient left ventricular ballooning (Takotsubo-like cardiomyopathy) as first presentation of pheochromocytoma. J Cardiovasc Med (Hagerstown) (2010) 0.78

Pressor reflex response to static muscular contraction: its afferent arm and possible neurotransmitters. Am J Cardiol (1988) 0.77

"Inverted" tako-tsubo cardiomyopathy due to exogenous catecholamines. Crit Care Resusc (2010) 0.76

Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med (2006) 8.74

Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA (2007) 3.48

Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial. Circulation (2010) 2.88

Design and methodology of the Occluded Artery Trial (OAT). Am Heart J (2005) 2.26

Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study. JACC Cardiovasc Interv (2008) 1.63

A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J (2010) 1.46

The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr (2007) 1.28

Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J (2009) 1.08

Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort. Am Heart J (2012) 1.06

Plaque rupture in stable coronary artery disease. JACC Cardiovasc Interv (2015) 1.06

Usefulness of tilt-induced heart rate changes in the differential diagnosis of vasovagal syncope and chronic autonomic failure. Clin Auton Res (2009) 1.01

Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction. Circulation (2011) 0.96

Cardiovascular disease in young women: a population at risk. Cardiol Rev (2011) 0.91

Women have less severe and extensive coronary atherosclerosis in fatal cases of ischemic heart disease: an autopsy study. Am Heart J (2011) 0.91

Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J (2009) 0.89

Sex and race are associated with the absence of epicardial coronary artery obstructive disease at angiography in patients with acute coronary syndromes. Clin Cardiol (2010) 0.87

A case of apical ballooning cardiomyopathy associated with duloxetine. Ann Intern Med (2008) 0.86

Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. Eur Heart J (2007) 0.85

Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients. Eur Heart J Acute Cardiovasc Care (2013) 0.83

Ambient Particulate Matter Air Pollution Exposure and Mortality in the NIH-AARP Diet and Health Cohort. Environ Health Perspect (2015) 0.82

Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarction. World J Cardiol (2010) 0.79

Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial). Am J Cardiol (2011) 0.78

Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT). Am Heart J (2011) 0.78

Relationship between proprioception at the knee joint and gait ataxia in HSAN III. Mov Disord (2013) 0.78

Heartbreak. Eur Heart J (2010) 0.75

Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT). Am Heart J (2009) 0.75

Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT). Am Heart J (2012) 0.75

Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT). J Card Fail (2012) 0.75

Effect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment. Am J Cardiol (2012) 0.75

Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock. Crit Care Med (2014) 0.75

Diabetes and ischemic heart disease death in people age 25-54: a multiple-cause-of-death analysis based on over 400 000 deaths from 1990 to 2008 in New York City. Clin Cardiol (2015) 0.75